Compare ATRC & BFLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ATRC | BFLY |
|---|---|---|
| Founded | 2000 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medical Electronics |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.3B |
| IPO Year | 2005 | 2020 |
| Metric | ATRC | BFLY |
|---|---|---|
| Price | $55.18 | $6.44 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 7 |
| Target Price | ★ $64.89 | $11.17 |
| AVG Volume (30 Days) | 740.8K | ★ 4.6M |
| Earning Date | 11-03-2026 | 10-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 74.74 | 8.82 |
| EPS | ★ 0.27 | N/A |
| Revenue | ★ $201,630,000.00 | $97,610,000.00 |
| Revenue This Year | $13.42 | $27.72 |
| Revenue Next Year | $12.24 | $21.24 |
| P/E Ratio | $215.07 | ★ N/A |
| Revenue Growth | 15.40 | ★ 18.96 |
| 52 Week Low | $25.36 | $1.90 |
| 52 Week High | $66.02 | $10.21 |
| Indicator | ATRC | BFLY |
|---|---|---|
| Relative Strength Index (RSI) | 42.15 | 42.40 |
| Support Level | $51.63 | $6.35 |
| Resistance Level | $61.70 | $9.86 |
| Average True Range (ATR) | 2.86 | 0.53 |
| MACD | -0.67 | -0.02 |
| Stochastic Oscillator | 3.26 | 27.95 |
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
Butterfly Network Inc is a digital health business transforming care with handheld, whole-body ultrasound. Powered by its proprietary Ultrasound-on-Chip technology, its solution enables the acquisition of imaging information from an affordable, powerful device that fits in a healthcare professional's pocket with a combination of cloud-connected software and hardware technology that is easily accessed through a mobile application. Butterfly iQ+ is an ultrasound device that can perform whole-body imaging in a single handheld probe using semiconductor technology. The company operates in one reportable segment, which includes all activities related to the development, manufacture, and sale of the Company's products, software, and other services.